I'm on board with the idea of a "Shareholder's Sentiment Update" maybe every couple (2-3) weeks, and I'd be happy to continue authoring them, with everyone's input as we did for the first letter. As their communications are issued by their preferred means (press release, web site postings, etc.), we can provide feedback and refine our questions and concerns. It appears they at least acknowledged some of the concerns we expressed in the initial letter, so maybe we can use this as an interactive communication tool. I would initially want to express our appreciation for the latest press release, but then delve into some of the new questions or concerns which it raises, such as:
Does the indicated use of the new funding replace the EV5 build and previously expressed goals, or can that also be accomplished with the current cash balance?
Can the roles of the COO and Engineering hire be expounded upon further, given the traditional job descriptions for these titles and the overlap the stated COO responsibilities share with the CFO duties?
Is the funding indeed sufficient to meet the goals of re-starting development at both Ximedica and Plexus?
What impact is anticipated on the overall schedule due to the fundraising effort bringing in only the minimum funding?
Is there an anticipated date by which another round of fundraising should be expected? (may not be answerable; smacks of inside info for trading; therefore maybe shouldn't even be asked).
With regard to succession planning mentioned in the press release, can they expound upon the scope and what the plan is to balance stability with the need for change?
I would like to give them some time to do a little more planning before sending out the next round of questions and concerns. Hopefully they will see this post and anticipate the future. Personally, I see a great potential benefit for the entire Titan community if we can maintain their attention and continue these interactions.
